The Oncology Institute

Today marks our 17th anniversary at The Oncology Institute. We are deeply grateful to our patients for trusting us with their care and allowing us to be part of their journey. We also want to thank our dedicated team for their unwavering commitment to making a difference everyday. As we look to the future, we remain committed to advancing cancer treatment and delivering the highest quality of care. Here’s to many more years of hope, healing, and innovation. Thank you for being part of our story! 💙

At The Oncology Institute, we believe it's important to spread awareness about different types of cancer because early detection and education can save lives. Appendix cancer is a rare and serious condition that starts in the cells lining the appendix. Though rare, with about 10 cases per million people annually, it’s crucial to raise awareness for better diagnosis and treatment. Common symptoms like abdominal pain, bloating, and increased girth can be mistaken for other conditions such as appendicitis or ovarian cysts, which is why appendix cancer is often misdiagnosed. Early detection and specialized treatment are essential for improving outcomes. If you or someone you know is experiencing these symptoms, consult with a specialist. Together, we can bring hope to those affected by rare diseases.

We’re thrilled to welcome Dr. Wendy Chen, D.O., to The Oncology Institute! A Board-Certified Medical Oncologist and Hematologist based in Tucson, Dr. Chen completed her fellowship at Yale School of Medicine and her Residency at Yale-New Haven Hospital. She earned her D.O. from Ohio University and a B.A. in Psychology from Amherst College. Dr. Chen also volunteers at Clinica Amistad, offering care to uninsured patients. Her experience spans private practice in Hawaii, Maui Memorial Hospital, and roles with Cigna and Arizona Oncology Associates. We’re excited about the expertise she brings to our team!

Join us in raising awareness and support for those affected by lung cancer. Lung cancer remains the leading cause of cancer death in the US, accounting for about 125,070 deaths in 2024. This year, approximately 234,580 new cases of lung cancer are expected to be diagnosed. Non-small cell lung cancer (NSCLC) makes up about 80-85% of these cases, while small cell lung cancer (SCLC) accounts for 10-15%. Risk factors include smoking, secondhand smoke, exposure to radon and asbestos, and certain workplace chemicals. Quitting smoking and early detection are crucial steps to reduce the risk and improve outcomes. Together, we can promote awareness, encourage early detection, and support ongoing research. Let's work towards a future where lung cancer no longer poses a threat to our loved ones.

Join Us for The Oncology Institute of Hope & Innovation Fellowship Event! Date: August 8, 2024 Time: 5:00 PM - 7:00 PM Pacific Daylight Time Since 2007, The Oncology Institute of Hope and Innovation (TOI) has been at the forefront of cancer care, delivering highly specialized, value-based treatments in community settings. With a growing network of over 100 clinicians and more than 700 teammates across 60+ clinic locations, TOI is revolutionizing oncology. Don't miss this unique opportunity to connect with us and learn more about our innovative approach to cancer care. Register now and be part of the future of oncology! https://lnkd.in/eBZqSPmt

July is Sarcoma and Bone Cancer Awareness Month! Join us in spreading hope and support for those affected by sarcoma and bone cancer. Sarcomas, a rare group of cancers, form in the bones or soft tissues like cartilage, fat, muscle, and blood vessels. Sarcomas account for a very small percentage of all adult cancers but have a significant impact on those affected. In 2024, approximately 13,590 cases of soft tissue sarcomas and 3,970 cases of bone and joint cancers are expected to be diagnosed in the United States. Risk factors for sarcomas include certain inherited disorders, past radiation therapy, exposure to specific chemicals, and long-term lymphedema. Understanding these risks is crucial for early detection and treatment. We are committed to raising awareness about sarcomas and bone cancers, promoting early detection, and supporting innovative research. Together, we can fight these rare cancers with hope and determination!

We are excited to welcome Dr. Michael Del Rosario to The Oncology Institute. Dr. Del Rosario is a Board-Certified Medical Oncologist and Hematologist with an impressive background in Biochemistry and Cell Biology from the University of California, San Diego, and a medical degree from St. George’s University, School of Medicine. We look forward to the expertise and dedication he will bring to our patients and community.

Join Us for The Oncology Institute of Hope & Innovation Fellowship Event! Date: August 8, 2024 Time: 5:00 PM - 7:00 PM Pacific Daylight Time Since 2007, The Oncology Institute of Hope and Innovation (TOI) has been at the forefront of cancer care, delivering highly specialized, value-based treatments in community settings. With a growing network of over 100 clinicians and more than 700 teammates across 60+ clinic locations, TOI is revolutionizing oncology. Don't miss this unique opportunity to connect with us and learn more about our innovative approach to cancer care. Register now and be part of the future of oncology! https://lnkd.in/eBZqSPmt

We are pleased to announce that Dr. Taras Benzar will present at the Pan Pacific Lymphoma Conference, a premier event gathering over 600 specialists in lymphoma and transplantation. Dr. Benzar's presentation will focus on orbital DLBCL (diffuse large B-cell lymphoma), he had this to say regarding his findings: "I believe that sharing this case can provide valuable insights and advance our understanding of this rare condition." Join us in celebrating Dr. Benzar's dedication to enhancing patient care and contributing to the scientific community. For more details on the conference, click here: https://lnkd.in/gkby9Cup

Congratulations to Edgardo S. Santos, MD, FACP, FASCO on being awarded the prestigious Fellow of the American Society of Clinical Oncology (FASCO) distinction! We are incredibly proud of Dr. Santos for this recognition, which celebrates his extraordinary volunteer service, dedication, and commitment to the American Society of Clinical Oncology (ASCO) and the field of oncology. This achievement is a testament to his unwavering commitment to excellence in oncology, and we are honored to have him as a part of The Oncology Institute family.